Home » Topics » BioWorld Science

BioWorld Science
RSS

CLDN6 identified as a tumor-promoting gene in gastric cancer

Oct. 30, 2019

Positive clinical data presented for omburtamab

Oct. 30, 2019

First green tea-triggered genetic control system reported

Oct. 30, 2019

Hypothermia activates hypoxia protein, benefits metabolism

Oct. 30, 2019

Alpha-synuclein and autophagy

Oct. 30, 2019

Clinical development of MOR-106 for atopic dermatitis ended for futility

Oct. 29, 2019

At Molecular Targets meeting, a bonanza of ways to thwart "undruggable" KRAS

Oct. 29, 2019

CARB-X award supports BioVersys' development of antimicrobial therapies

Oct. 29, 2019

AstraZeneca reports promising PFS data with Imfinzi and tremelimumab in stage IV NSCLC

Oct. 29, 2019

European Commission approves Bavencio with axitinib for first-line advanced RCC

Oct. 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...